FindTrial
Sign In

A single-cell sequencing-based study to explore differences in colonic mucosal expression in patients with irritable bowel syndrome

A single-cell sequencing-based study to explore differences in colonic mucosal expression in patients with irritable bowel syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090317
Enrollment
Unknown
Registered
2024-09-27
Start date
2024-10-08
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

irritable bowel syndrome

Interventions

Observation Group 1:None
Observation Group 2:None

Sponsors

Affiliated Hospital of North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with an outpatient diagnosis considering Irritable Bowel Syndrome/IBS (constipation type/IBS-C, diarrhoea type/IBS-D)

Exclusion criteria

Exclusion criteria: Inflammatory bowel disease, enteritis, intestinal polyps, intestinal diverticula and other organic bowel diseases.

Design outcomes

Primary

MeasureTime frame
Colonic mucosal expression profile;—

Secondary

MeasureTime frame
Spontaneous bowel movement;Bristol stool score;Abdominal pain score;Abdominal bloating Score;IBS symptom severity scale score;—

Countries

China

Contacts

Public ContactXue-gui Tang

Affiliated Hospital of North Sichuan Medical College

txg668nc@sohu.com+86 189 8918 3808

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026